Bulten AB (publ) (FRA:3FB)

Blueprint Medicines Revenue

Bulten AB had revenue of 1.34B SEK in the quarter ending June 30, 2025, a decrease of -8.80%. This brings the company's revenue in the last twelve months to 5.58B, down -6.14% year-over-year. In the year 2024, Bulten AB had annual revenue of 5.81B with 0.87% growth.

• Revenue (ttm): 5.58B SEK
• Revenue Growth: -6.14%
• P/S Ratio: 0.22
• Revenue / Employee: 3.22M SEK
• Employees: 1,731
• Market Cap: 108.78M USD

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.81B	50.00M	0.87%
Dec 31, 2023	5.76B	1.28B	28.68%
Dec 31, 2022	4.47B	744.00M	19.95%
Dec 31, 2021	3.73B	535.00M	16.74%
Dec 31, 2020	3.20B	102.00M	3.30%